Novel Therapeutic Approaches for the Management of Elevated Lipoprotein(a): From Traditional Agents to Future Treatment Options

Cardiovascular disease is the leading cause of mortality worldwide. Despite the availability of effective low-density lipoprotein cholesterol (LDL-C) lowering agents, an increased cardiovascular risk is still observed in individuals with therapeutic LDL-C levels. One of these cardiovascular risk fac...

Descripció completa

Dades bibliogràfiques

Autors principals:	György Paragh, Péter Zilahi, László Róbert Kolozsvári, Hajnalka Lőrincz, Péter Fülöp, Mariann Harangi
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2024-03-01
Col·lecció:	Life
Matèries:	lipoprotein(a) lipid-lowering therapy lipoprotein apheresis proprotein convertase subtilisin kexin type 9 inhibitor antisense oligonucleotide small interfering RNA
Accés en línia:	https://www.mdpi.com/2075-1729/14/3/374
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!